Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Session History
Support Wiki
Direct access to
document ID:

          Display Documents

ID: 327730.0, MPI für Dynamik komplexer technischer Systeme / Bioprocess Engineering
Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus
Authors:Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.
Name of Conference/Meeting:BioProcess Technology - Asia
Place of Conference/Meeting:Singapore
(Start) Date of Conference/Meeting
End Date of Conference/Meeting 
Audience:Not Specified
Intended Educational Use:No
Abstract / Description:Due to its annual death rate and the potential to cause pandemics, Influenza remains a major public health concern. Efforts to control the annual spread of influenza have centered on prophylactic vaccinations. Influenza viruses for human vaccine production are currently grown on embryonated eggs. However, this production process conveys major drawbacks such as lack of scalability, inability of some strains to replicate on eggs to high enough yields, and possible allergic reactions induced by egg proteins. These limitations emphasize the need for an alternative process. In recent years several continuous cell lines such as the Madin-Darby canine kidney (MDCK) have been successfully established for the production of influenza vaccines. These processes require the modification of existing downstream strategies to account for the modified upstream technology.

The presented study focuses on the development of two downstream processing schemes for the purification of human Influenza A/PR/8/34 (H1N1) virus. Purification scheme 1 is based on a combination of size exclusion and anion exchange chromatography. Scheme 2 is centered on a lectin affinity chromatography. Both downstream processes represent a promising tool for the effective processing of MDCK-cell derived vaccines. In addition, the glycan analysis provides a powerful tool for the quality control of cell and egg derived antigens.
Document Type:Talk at Event
Communicated by:Udo Reichl
Affiliations:MPI für Dynamik komplexer technischer Systeme/Bioprocess Engineering
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.